Senate subcommittee advances amended SB103 requiring prominent labeling for cell‑cultivated meat products

The Senate Agriculture and Natural Resources Subcommittee on an unspecified date advanced Senate Bill 103 as amended, requiring that products made from animal cells grown outside a live animal carry conspicuous front‑of‑package labeling that identifies them as “artificial/cell cultivated” or “cell cultured,” and placing primary responsibility for that labeling on manufacturers rather than retail outlets.

Senate staff member Miss Maroney summarized the bill for the subcommittee, saying the measure “defines cell cultivated or, as we know it, artificial food products and requires that any cell cultivated food product in the state must have a notice on the packaging that indicates that it is not naturally grown beef, poultry, fish, crustacean, or any other animal protein.” The amended language discussed in the hearing keeps the requirement that the notice be “conspicuous” on the front of the package and clarifies that retailers are exempt from the labeling requirement unless they also manufacture the product or sell manufacturer‑branded items.

The bill was introduced and discussed as a consumer‑disclosure measure rather than a ban. “Consumers deserve to know quickly and easily what they were purchasing,” said David Rush, representing the South Carolina Poultry Federation, who emphasized the economic importance of traditional animal agriculture. Rush told the panel that a 2022 Darla Moore School of Business study for the Department of Agriculture found the poultry industry’s impact at nearly $4,000,000,000 (a pre‑COVID figure he said may be higher now) and warned that producers and allied businesses could be affected if labeling is not clear.

Supporters of strict labeling, including Travis Mitchell, executive director of the South Carolina Cattlemen’s Association, said the labeling will protect producers from being undercut by products that “trade on real beef’s hard earned reputation for quality and wholesomeness.” Mitchell said, “Labels that mislead consumers or blur the lines between these products and real beef must be prohibited.”

Representatives of the alternative‑protein sector urged caution about overly prescriptive state rules. Tamar Lieberman of the Good Food Institute said cultivated meat firms want transparency but warned that state‑specific label mandates can raise interstate‑commerce and First Amendment issues and could deter companies from selling in the state. Lieberman said two U.S. companies had completed FDA premarket assessments and that limited restaurant pilots had occurred, but those pilots are paused while companies work on mass‑production.

The amendment explained by Miss Maroney removes a retail burden by excluding typical retail sales from the definitions of “sells” or “offers for sale” unless the retailer is also the manufacturer. The amendment also revises the bill’s language to describe products as “artificial/cell cultivated” and preserves a definition that the product begins from a “sample of living animal cells.” Maroney summarized the prohibitions in the amended language: “No person advertising, offering for sale, or selling a food product shall engage in any misleading or deceptive practice, including misrepresenting an artificial/cell cultured product as meat that is derived from harvested production beef, poultry, fish, crustacean, or any other animal protein.”

After discussion and a unanimous‑consent conforming change to the bill’s definitions, the subcommittee adopted the amendment and then voted to give SB103 a favorable report to the full Senate Agriculture and Natural Resources Committee. The votes were recorded by voice; the chair announced the ayes and said there was no opposition.

The subcommittee also discussed regulatory scope. Maroney said the bill allows the Department of Agriculture to promulgate regulations “as necessary,” but the current text states no additional regulations are required from the statute itself.

The hearing included questions from multiple senators about environmental claims, product safety, and the meaning of terminology such as “cell cultivated” versus alternative terms. David Rush and other traditional‑industry witnesses raised concerns about environmental modeling and potential impacts on electricity use if cultivated products were produced at scale; Lieberman and other witnesses said available studies and regulatory review are still developing and that cultivated products are not yet sold at scale in the United States.

SB103 as amended will move to the full Senate Agriculture and Natural Resources Committee for further consideration.